Transaction · 0000950170-25-036671

BURNETT JOSEPH MICHAEL

BURNETT JOSEPH MICHAEL, CEO, PRES, reported a transaction classified as withholding at ClearPoint Neuro, Inc. involving 26160.000000 shares for an estimated $345050.40. Reported holdings after the transaction were 271123.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

withholdingSEC transaction code FCEO, PRES
CLPTClearPoint Neuro, Inc.
Filing timeMar 10
Trade dateMar 06, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
—
Pre-filing
1mo ago1w ago1d ago
Returns since
7d30d90d180d1y

CLPT price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
CLPT since 2025-03-10Filed 543 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
withholding
Code F
Identifier
0000950170-25-036671
Common Stock
Transaction date
Mar 06, 2025
Filed Mar 10, 2025, 11:44 PM · 4d delay
Shares
26.1k sh
$1.31k per share
Estimated value
-$34.5M
Computed from shares × price
Holdings after
271k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership
-16score
Filing-only score

-16

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

CEO and President

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. This transaction represents the settlement of restricted stock units in s…

  2. F2

    Represents the amount of shares delivered to CLPT to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock.

Original filing · 0000950170-25-036671
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

CLPT